I was educated and trained at
Albert Einstein College of Medicine of Yeshiva University, NY
University of Rochester Medical Center
UNIVERSITY OF NORTH CAROLINA HOSPITAL
Associate Medical Director, Carolina Fitness Program - 1988-1991
Co-Director, UNC Center for Functional GI and Motility Diseases - 1994-present
Ad Hoc Member, Consultation-Liaison Division, Dept of Psychiatry - 1978-present
Co-Director, Medical-Psychiatric Liaison Program, Faculty-Resident Study Group - 1977-1990
Dr. Douglas Drossman
I've won the following awards
Top Doctor, US News and World Report, 2011
Patients' Choice Award, 2008, 2009
Presidential Who's Who Among Business and Professional Achievers, 2010
Top Gastroenterologist-South, Women's Health Magazine November 2008
Top Gastroenterologist, Men's Health Magazine April 2007
AGA Mentors Research Scholar Award, 2007
AGA Fellow, 2006
AGA Miles snd Shirley Fiterman Joseph B. Kirsner Award in Clinical Research, 2005
AGA DEistinguished Educator Award, 2004
Who's Who in America, 2004-2011
APS President's Award, 2003
ACG Clinical Scholar Award, 2002-2003
America's Top Doctors, Castle Connolly Medical Ltd., 2001-2011
Functional Brain-Gut Research Group Research Scientist Award, 2001
Janssen Award for Clinical Research in Digestive Diseases, 1999
Development and validation of the irritable bowel syndrome satisfaction with care scale.
Clin. Gastroenterol. Hepatol., Dec;9(12):1065-71.e1-2 (2011)
Severity in irritable bowel syndrome: a Rome Foundation Working Team report.
Am. J. Gastroenterol., Oct;106(10):1749-59; quiz 1760 (2011)
Narcotic use for inflammatory bowel disease and risk factors during hospitalization.
Inflamm. Bowel Dis., May;18(5):869-76 (2012)
Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar.
J. Clin. Gastroenterol., Mar;43(3):214-20 (2009)
Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms.
Am. J. Gastroenterol., Dec;104(12):2897-902 (2009)
Cognitive factors affect treatment response to medical and psychological treatments in functional bowel disorders.
Am. J. Gastroenterol., Jun;105(6):1397-406 (2010)
Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review.
Am. J. Gastroenterol., Apr;105(4):814-20; quiz 813, 821 (2010)
Quality of life measures in irritable bowel syndrome.
Expert Rev Gastroenterol Hepatol., Jun;4(3):277-84 (2010)
Abuse, trauma, and GI illness: is there a link?
Am. J. Gastroenterol., Jan;106(1):14-25 (2011)
Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
Am. J. Gastroenterol., Oct;106(10):1813-20 (2011)
Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders.
Dig. Dis. Sci., Jun;54(6):1284-91 (2009)
A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity.
Dig. Dis. Sci., Jul;54(7):1532-41 (2009)
International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.
J. Clin. Gastroenterol., Jul;43(6):541-50 (2009)
Not all side effects associated with tricyclic antidepressant therapy are true side effects.
Clin. Gastroenterol. Hepatol., Apr;7(4):446-51 (2009)
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.
Aliment. Pharmacol. Ther., Feb;29(3):329-41 (2009)
Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS.
J. Clin. Gastroenterol., 42(10):1080-8 (2008)
The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
Clin. Gastroenterol. Hepatol., Jan;7(1):48-53 (2009)
Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
Am. J. Gastroenterol., Oct;103(10):2562-9 (2008)
Commentary: sociocultural factors in medicine and gastrointestinal research.
Eur J Gastroenterol Hepatol., Jul;20(7):593-5 (2008)
Severe and refractory chronic abdominal pain: treatment strategies.
Clin. Gastroenterol. Hepatol., Sep;6(9):978-82 (2008)